US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Ultragenyx Pharmaceutical

19.38

-0.6200-3.10%

Post-market: 19.30-0.0800-0.41%19:52 EDT

Volume:1.53M

Turnover:29.71M

Market Cap:1.87B

PE:-3.32

High:20.09

Open:20.00

Low:19.10

Close:20.00

52wk High:42.37

52wk Low:18.29

Shares:96.48M

Float Shares:92.79M

Volume Ratio:0.55

T/O Rate:1.65%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.8316

EPS(LYR):-5.8316

ROE:-608.47%

ROA:-22.03%

PB:-23.37

PE(LYR):-3.32

Loading ...

Overview Company News Filings

Is It Time To Reconsider Ultragenyx Pharmaceutical (RARE) After Its Prolonged Share Price Slump?

Simply Wall St.

Ultragenyx announces annual stockholders meeting; FY2025 revenue grows 20%

BROAD ARROW PRESENTS RARE OPPORTUNITY TO ACQUIRE FERRARI MONZA SP2 AT CONCORSO D’ELEGANZA VILLA D’ESTE AUCTION

Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Alnylam Pharma (ALNY) and Ultragenyx Pharmaceutical (RARE)

Why Ultragenyx (RARE) Is Down 14.4% After Positive Phase 3 DTX301 Gene Therapy Results

Simply Wall St.

Goldman Sachs Downgrades Ultragenyx Pharmaceutical to Neutral From Buy, Adjusts PT to $25 From $61

MT Newswires Live

Ultragenyx downgraded to Neutral from Buy at Goldman Sachs

Ultragenyx grants 10,839 restricted stock units under employment inducement plan

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Analysts Conflicted on These Healthcare Names: Immutep (IMMP) and Ultragenyx Pharmaceutical (RARE)

Ultragenyx's Gene Therapy Study Shows Ammonia Reduction In Rare Metabolic Disorder

Benzinga_recent_news

Ultragenyx's gene therapy helps control ammonia levels in late-stage study

Ultragenyx Phase 3 Enh3ance study showed statistically significant results

Ultragenyx reports Phase 3 Enh3ance trial shows DTX301 cuts plasma ammonia AUC by 18% at Week 36

Ultragenyx Announces Positive 36-Week Data From Phase 3 Study of Dtx301 Aav8 Gene Therapy for the Treatment of Ornithine Transcarbamylase (Otc) Deficiency

THOMSON REUTERS

Ultragenyx Pharmaceutical Inc - Dtx301 Shows 18% Reduction in 24-Hour Plasma Ammonia at Week 36 Versus Placebo

THOMSON REUTERS

Ultragenyx Pharmaceutical Inc - Dtx301 Well Tolerated With Acceptable Safety Profile

THOMSON REUTERS

Ultragenyx Pharmaceutical Inc - Fewer Hyperammonemic Crises and No Deaths in Dtx301 Group Compared to Placebo

THOMSON REUTERS

Ultragenyx Pharmaceutical Inc - Secondary Endpoint Data on Treatment Burden Reduction Expected First Half 2027

THOMSON REUTERS

Ultragenyx Announces Positive 36-Week Data from Phase 3 Study of DTX301 AAV8 Gene Therapy for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/RARE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RARE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RARE\",,,,,undefined,":{"symbol":"RARE","market":"US","secType":"STK","nameCN":"Ultragenyx Pharmaceutical","latestPrice":19.38,"timestamp":1774641600000,"preClose":20,"halted":0,"volume":1530550,"hourTrading":{"tag":"盘后","latestPrice":19.3,"preClose":19.38,"latestTime":"19:52 EDT","volume":65969,"amount":1277704.95,"timestamp":1774655522219,"change":-0.08,"changeRate":-0.004128,"amplitude":0.030212},"delay":0,"changeRate":-0.03100000000000005,"floatShares":92794919,"shares":96477569,"eps":-5.831643,"marketStatus":"Market Closed","change":-0.62,"latestTime":"03-27 16:00:00 EDT","open":20,"high":20.0918,"low":19.1,"amount":29708272.4267,"amplitude":0.04959,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.831643,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1391144400000,"exchange":"NASDAQ","adjPreClose":20,"preHourTrading":{"tag":"盘前","latestPrice":19.98,"preClose":20,"latestTime":"09:02 EDT","volume":542,"amount":10841.850387999999,"timestamp":1774616571106,"change":-0.02,"changeRate":-0.001,"amplitude":0.05},"postHourTrading":{"tag":"盘后","latestPrice":19.3,"preClose":19.38,"latestTime":"19:52 EDT","volume":65969,"amount":1277704.95,"timestamp":1774655522219,"change":-0.08,"changeRate":-0.004128,"amplitude":0.030212},"volumeRatio":0.553271733178923,"impliedVol":0.4363,"impliedVolPercentile":0.2112},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RARE\",,,,,undefined,":{"symbol":"RARE","floatShares":92794919,"roa":"-22.03%","roe":"-608.47%","lyrEps":-5.831643,"volumeRatio":0.553271733178923,"shares":96477569,"dividePrice":0,"high":20.0918,"amplitude":0.04959,"preClose":20,"low":19.1,"week52Low":18.29,"pbRate":"-23.37","psRate":"2.78","week52High":42.37,"institutionHeld":0,"latestPrice":19.38,"eps":-5.831643,"divideRate":0,"volume":1530550,"delay":0,"ttmEps":-5.831643,"open":20,"prevYearClose":23,"prevWeekClose":19.87,"prevMonthClose":23.39,"prevQuarterClose":23,"fiveDayClose":19.87,"twentyDayClose":23.39,"sixtyDayClose":22.78},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RARE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-12","symbol":"RARE","fiscalQuarterEnding":"2025/12","expectedEps":-1.2,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1770872400000,"reportTimeType":"post","actualEps":-1.39},{"market":"US","date":"2026-01-12","symbol":"RARE","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1768194000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-11-04","symbol":"RARE","fiscalQuarterEnding":"2025/09","expectedEps":-1.23,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":-1.81},{"market":"US","date":"2025-08-05","symbol":"RARE","fiscalQuarterEnding":"2025/06","expectedEps":-1.27,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"post","actualEps":-1.17},{"market":"US","date":"2025-05-06","symbol":"RARE","fiscalQuarterEnding":"2025/03","expectedEps":-1.54,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"post","actualEps":-1.57}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RARE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RARE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.6,"hold":0.1,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":20,"updateTime":1774411200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RARE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RARE","date":"2026-03-27","current":-3.323249,"percent":0.995086,"low":-41.221121,"twenty":-10.913611,"median":-6.247248,"eighty":-4.551596,"high":-3.102524,"avg":-9.145418,"sd":7.849579,"marketCap":1928595760},"quantilePoints":[{"date":"2021-04-01","current":-40.621841,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":7578654420},{"date":"2021-04-09","current":-37.133817,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6927907769},{"date":"2021-04-16","current":-39.014192,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7278721807},{"date":"2021-04-23","current":-39.42687,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7355713438},{"date":"2021-04-30","current":-40.376431,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7532869144},{"date":"2021-05-07","current":-37.945412,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7728797410},{"date":"2021-05-14","current":-36.736115,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7482485435},{"date":"2021-05-21","current":-35.563263,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7243596560},{"date":"2021-05-28","current":-33.697964,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6863668773},{"date":"2021-06-04","current":-30.543853,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6221233155},{"date":"2021-06-11","current":-33.697964,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6863668773},{"date":"2021-06-18","current":-31.448341,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6405461016},{"date":"2021-06-25","current":-31.087209,"twenty":-29.984017,"median":-15.161272,"eighty":-8.834973,"marketCap":6331904837},{"date":"2021-07-02","current":-31.213108,"twenty":-30.257731,"median":-15.161272,"eighty":-8.834973,"marketCap":6357548275},{"date":"2021-07-09","current":-30.262236,"twenty":-30.265324,"median":-15.161272,"eighty":-8.834973,"marketCap":6163872832},{"date":"2021-07-16","current":-28.271038,"twenty":-30.233301,"median":-15.161272,"eighty":-8.834973,"marketCap":5758301606},{"date":"2021-07-23","current":-27.406308,"twenty":-29.984017,"median":-15.161272,"eighty":-8.834973,"marketCap":5582171673},{"date":"2021-07-30","current":-26.44881,"twenty":-29.79768,"median":-15.161272,"eighty":-8.834973,"marketCap":5387146575},{"date":"2021-08-06","current":-17.083279,"twenty":-29.687102,"median":-15.161272,"eighty":-8.834973,"marketCap":6003491310},{"date":"2021-08-13","current":-17.901732,"twenty":-29.496644,"median":-15.161272,"eighty":-8.834973,"marketCap":6291116204},{"date":"2021-08-20","current":-15.473397,"twenty":-29.315394,"median":-15.15171,"eighty":-8.834973,"marketCap":5437738569},{"date":"2021-08-27","current":-18.1353,"twenty":-29.179331,"median":-15.15171,"eighty":-8.834973,"marketCap":6373197837},{"date":"2021-09-03","current":-19.766415,"twenty":-28.984947,"median":-15.15171,"eighty":-8.834973,"marketCap":6946412544},{"date":"2021-09-10","current":-19.629363,"twenty":-28.634625,"median":-15.15171,"eighty":-8.834973,"marketCap":6898248941},{"date":"2021-09-17","current":-18.969196,"twenty":-28.497709,"median":-15.15171,"eighty":-8.834973,"marketCap":6666249616},{"date":"2021-09-24","current":-18.359217,"twenty":-28.236842,"median":-15.15171,"eighty":-8.834973,"marketCap":6451887666},{"date":"2021-10-01","current":-16.948157,"twenty":-28.151413,"median":-15.15171,"eighty":-8.834973,"marketCap":5956006068},{"date":"2021-10-08","current":-15.759084,"twenty":-28.053185,"median":-15.15171,"eighty":-8.834973,"marketCap":5538135938},{"date":"2021-10-15","current":-15.442512,"twenty":-27.812745,"median":-15.15171,"eighty":-8.834973,"marketCap":5426884800},{"date":"2021-10-22","current":-15.098916,"twenty":-27.55852,"median":-15.082382,"eighty":-8.834973,"marketCap":5306136613},{"date":"2021-10-29","current":-16.199195,"twenty":-27.366816,"median":-15.082382,"eighty":-8.834973,"marketCap":5692802155},{"date":"2021-11-05","current":-15.975791,"twenty":-27.236045,"median":-15.082382,"eighty":-8.834973,"marketCap":5680639831},{"date":"2021-11-12","current":-15.43713,"twenty":-27.171258,"median":-15.082382,"eighty":-8.834973,"marketCap":5489103979},{"date":"2021-11-19","current":-15.205181,"twenty":-26.927437,"median":-15.06031,"eighty":-8.834973,"marketCap":5406627687},{"date":"2021-11-26","current":-14.662686,"twenty":-26.731524,"median":-14.936554,"eighty":-8.834973,"marketCap":5213728590},{"date":"2021-12-03","current":-14.570673,"twenty":-26.554402,"median":-14.855697,"eighty":-8.834973,"marketCap":5181010722},{"date":"2021-12-10","current":-14.932975,"twenty":-26.360162,"median":-14.855697,"eighty":-8.834973,"marketCap":5309837327},{"date":"2021-12-17","current":-16.265249,"twenty":-26.205264,"median":-14.855697,"eighty":-8.834973,"marketCap":5783564791},{"date":"2021-12-23","current":-16.244163,"twenty":-25.908959,"median":-14.855697,"eighty":-8.834973,"marketCap":5776066946},{"date":"2021-12-31","current":-16.119562,"twenty":-25.241061,"median":-14.855697,"eighty":-8.834973,"marketCap":5731761500},{"date":"2022-01-07","current":-14.145112,"twenty":-24.735967,"median":-14.855038,"eighty":-8.83563,"marketCap":5029690582},{"date":"2022-01-14","current":-13.811564,"twenty":-24.180303,"median":-14.806289,"eighty":-8.83563,"marketCap":4911088311},{"date":"2022-01-21","current":-12.876097,"twenty":-23.989848,"median":-14.747324,"eighty":-8.83563,"marketCap":4578456653},{"date":"2022-01-28","current":-12.651814,"twenty":-23.661155,"median":-14.661474,"eighty":-8.83563,"marketCap":4498706850},{"date":"2022-02-04","current":-13.154053,"twenty":-23.48091,"median":-14.600648,"eighty":-8.83563,"marketCap":4677291879},{"date":"2022-02-11","current":-10.94589,"twenty":-23.205637,"median":-14.505395,"eighty":-8.83563,"marketCap":4969707824},{"date":"2022-02-18","current":-10.194721,"twenty":-23.125145,"median":-14.35823,"eighty":-8.83563,"marketCap":4628658273},{"date":"2022-02-25","current":-10.307809,"twenty":-22.914219,"median":-14.283419,"eighty":-8.83563,"marketCap":4680003006},{"date":"2022-03-04","current":-9.594133,"twenty":-22.459434,"median":-14.16111,"eighty":-8.83563,"marketCap":4355976111},{"date":"2022-03-11","current":-9.996053,"twenty":-21.586553,"median":-14.118393,"eighty":-8.83563,"marketCap":4538458067},{"date":"2022-03-18","current":-10.663883,"twenty":-21.326675,"median":-14.069914,"eighty":-8.83563,"marketCap":4841669529},{"date":"2022-03-25","current":-10.524816,"twenty":-21.159681,"median":-13.968769,"eighty":-8.83563,"marketCap":4778529385},{"date":"2022-04-01","current":-11.823798,"twenty":-21.003206,"median":-13.863231,"eighty":-8.83563,"marketCap":5368299964},{"date":"2022-04-08","current":-12.514551,"twenty":-20.910296,"median":-13.803148,"eighty":-8.83563,"marketCap":5681919142},{"date":"2022-04-14","current":-13.050955,"twenty":-20.848103,"median":-13.773354,"eighty":-8.83563,"marketCap":5925459699},{"date":"2022-04-22","current":-11.470781,"twenty":-20.717776,"median":-13.670793,"eighty":-8.83563,"marketCap":5208021136},{"date":"2022-04-29","current":-10.878745,"twenty":-20.624785,"median":-13.564241,"eighty":-8.83563,"marketCap":4939222202},{"date":"2022-05-06","current":-8.557526,"twenty":-20.519008,"median":-13.487652,"eighty":-8.833003,"marketCap":4023783190},{"date":"2022-05-13","current":-7.654777,"twenty":-20.519008,"median":-13.402239,"eighty":-8.786823,"marketCap":3599306930},{"date":"2022-05-20","current":-7.220506,"twenty":-20.519008,"median":-13.35812,"eighty":-8.748709,"marketCap":3395110773},{"date":"2022-05-27","current":-7.233891,"twenty":-20.519008,"median":-13.323757,"eighty":-8.718034,"marketCap":3401404490},{"date":"2022-06-03","current":-7.645854,"twenty":-20.519008,"median":-13.277877,"eighty":-8.684283,"marketCap":3595111119},{"date":"2022-06-10","current":-7.418308,"twenty":-20.519008,"median":-13.17025,"eighty":-8.65258,"marketCap":3488117927},{"date":"2022-06-17","current":-7.925453,"twenty":-20.519008,"median":-13.057111,"eighty":-8.633594,"marketCap":3726579878},{"date":"2022-06-24","current":-9.008157,"twenty":-20.52732,"median":-13.025475,"eighty":-8.615488,"marketCap":4235671668},{"date":"2022-07-01","current":-9.317501,"twenty":-20.52732,"median":-12.971944,"eighty":-8.615488,"marketCap":4381126466},{"date":"2022-07-08","current":-9.836545,"twenty":-20.52732,"median":-12.903988,"eighty":-8.615488,"marketCap":4625182832},{"date":"2022-07-15","current":-9.62982,"twenty":-20.52732,"median":-12.867014,"eighty":-8.615488,"marketCap":4527979867},{"date":"2022-07-22","current":-7.657752,"twenty":-20.52732,"median":-12.683542,"eighty":-8.593044,"marketCap":3600705534},{"date":"2022-07-29","current":-7.375537,"twenty":-20.52732,"median":-12.576503,"eighty":-8.565198,"marketCap":3731564327},{"date":"2022-08-05","current":-7.696694,"twenty":-20.52732,"median":-12.447093,"eighty":-8.50432,"marketCap":3894049860},{"date":"2022-08-12","current":-7.138822,"twenty":-20.52732,"median":-12.354843,"eighty":-8.455092,"marketCap":3611801282},{"date":"2022-08-19","current":-6.78721,"twenty":-20.52732,"median":-12.331685,"eighty":-8.434672,"marketCap":3433907638},{"date":"2022-08-26","current":-6.852272,"twenty":-20.52732,"median":-12.331685,"eighty":-8.389678,"marketCap":3466824966},{"date":"2022-09-02","current":-6.61002,"twenty":-20.52732,"median":-12.331685,"eighty":-8.359036,"marketCap":3344260447},{"date":"2022-09-09","current":-6.816281,"twenty":-20.52732,"median":-12.331685,"eighty":-8.331801,"marketCap":3448615380},{"date":"2022-09-16","current":-6.371921,"twenty":-20.52732,"median":-12.331685,"eighty":-8.289414,"marketCap":3223797034},{"date":"2022-09-23","current":-5.744834,"twenty":-20.52732,"median":-12.331685,"eighty":-8.245615,"marketCap":2906530022},{"date":"2022-09-30","current":-5.732376,"twenty":-20.52732,"median":-12.331685,"eighty":-8.208124,"marketCap":2900226703},{"date":"2022-10-07","current":-5.25064,"twenty":-20.52732,"median":-12.331685,"eighty":-8.150659,"marketCap":2656498403},{"date":"2022-10-14","current":-5.130206,"twenty":-20.52732,"median":-12.331685,"eighty":-8.077486,"marketCap":2595566328},{"date":"2022-10-21","current":-5.328161,"twenty":-20.52732,"median":-12.331685,"eighty":-8.010065,"marketCap":2695719049},{"date":"2022-10-28","current":-5.642396,"twenty":-20.52732,"median":-12.331685,"eighty":-7.967887,"marketCap":2854702739},{"date":"2022-11-04","current":-3.646694,"twenty":-20.52732,"median":-12.331685,"eighty":-7.881082,"marketCap":2472626416},{"date":"2022-11-11","current":-3.779038,"twenty":-20.52732,"median":-12.331685,"eighty":-7.854126,"marketCap":2562361653},{"date":"2022-11-18","current":-3.721138,"twenty":-20.52732,"median":-12.331685,"eighty":-7.7969,"marketCap":2523102487},{"date":"2022-11-25","current":-3.693221,"twenty":-20.52732,"median":-12.331685,"eighty":-7.738619,"marketCap":2504173960},{"date":"2022-12-02","current":-4.153323,"twenty":-20.52732,"median":-12.331685,"eighty":-7.69117,"marketCap":2816144121},{"date":"2022-12-09","current":-4.202952,"twenty":-20.52732,"median":-12.331685,"eighty":-7.649461,"marketCap":2849794835},{"date":"2022-12-16","current":-4.717852,"twenty":-20.52732,"median":-12.331685,"eighty":-7.588745,"marketCap":3198920992},{"date":"2022-12-23","current":-4.499692,"twenty":-20.52732,"median":-12.331685,"eighty":-7.55634,"marketCap":3050998062},{"date":"2022-12-30","current":-4.790228,"twenty":-20.52732,"median":-12.331685,"eighty":-7.468808,"marketCap":3247994949},{"date":"2023-01-06","current":-4.824348,"twenty":-20.52732,"median":-12.331685,"eighty":-7.468808,"marketCap":3271129815},{"date":"2023-01-13","current":-4.502794,"twenty":-20.52732,"median":-12.331685,"eighty":-7.468808,"marketCap":3053101231},{"date":"2023-01-20","current":-4.383891,"twenty":-20.52732,"median":-12.331685,"eighty":-7.468808,"marketCap":2972479729},{"date":"2023-01-27","current":-4.520371,"twenty":-20.52732,"median":-12.331685,"eighty":-7.419224,"marketCap":3065019192},{"date":"2023-02-03","current":-4.728192,"twenty":-20.52732,"median":-12.331685,"eighty":-7.265696,"marketCap":3205931557},{"date":"2023-02-10","current":-4.549321,"twenty":-20.52732,"median":-12.331685,"eighty":-7.228067,"marketCap":3084648776},{"date":"2023-02-17","current":-4.834822,"twenty":-20.52732,"median":-12.331685,"eighty":-7.193971,"marketCap":3420254921},{"date":"2023-02-24","current":-4.342506,"twenty":-20.52732,"median":-12.331685,"eighty":-7.118611,"marketCap":3071980143},{"date":"2023-03-03","current":-4.536058,"twenty":-20.52732,"median":-12.331685,"eighty":-7.091607,"marketCap":3208902687},{"date":"2023-03-10","current":-3.847212,"twenty":-20.52732,"median":-12.331685,"eighty":-7.007538,"marketCap":2721598865},{"date":"2023-03-17","current":-3.824383,"twenty":-20.52732,"median":-12.331685,"eighty":-6.964752,"marketCap":2705449027},{"date":"2023-03-24","current":-3.740015,"twenty":-20.52732,"median":-12.331685,"eighty":-6.882782,"marketCap":2645764841},{"date":"2023-03-31","current":-3.980217,"twenty":-20.519008,"median":-12.327325,"eighty":-6.84769,"marketCap":2815689228},{"date":"2023-04-06","current":-3.845227,"twenty":-20.519008,"median":-12.327325,"eighty":-6.817229,"marketCap":2720194531},{"date":"2023-04-14","current":-3.834309,"twenty":-20.52732,"median":-12.331685,"eighty":-6.790561,"marketCap":2712470696},{"date":"2023-04-21","current":-4.095356,"twenty":-20.52732,"median":-12.331685,"eighty":-6.741883,"marketCap":2897140588},{"date":"2023-04-28","current":-4.242476,"twenty":-20.52732,"median":-12.331685,"eighty":-6.708105,"marketCap":3001216442},{"date":"2023-05-05","current":-4.503028,"twenty":-20.52732,"median":-12.331685,"eighty":-6.653176,"marketCap":3238005775},{"date":"2023-05-12","current":-4.638891,"twenty":-20.543943,"median":-12.127091,"eighty":-6.641982,"marketCap":3335701281},{"date":"2023-05-19","current":-5.014059,"twenty":-20.543943,"median":-12.030107,"eighty":-6.608226,"marketCap":3605474618},{"date":"2023-05-26","current":-4.91559,"twenty":-20.543943,"median":-11.942999,"eighty":-6.574925,"marketCap":3534667968},{"date":"2023-06-02","current":-4.885064,"twenty":-20.543943,"median":-11.851539,"eighty":-6.547631,"marketCap":3512717906},{"date":"2023-06-09","current":-5.079049,"twenty":-20.543943,"median":-11.661746,"eighty":-6.51973,"marketCap":3652207007},{"date":"2023-06-16","current":-4.811212,"twenty":-20.543943,"median":-11.483123,"eighty":-6.479975,"marketCap":3459612919},{"date":"2023-06-21","current":-4.936268,"twenty":-20.510696,"median":-11.421308,"eighty":-6.417082,"marketCap":3549537364},{"date":"2023-06-30","current":-4.593595,"twenty":-20.487227,"median":-11.238841,"eighty":-6.371161,"marketCap":3303130222},{"date":"2023-07-07","current":-4.482325,"twenty":-20.498962,"median":-11.187498,"eighty":-6.365701,"marketCap":3223118708},{"date":"2023-07-21","current":-4.237136,"twenty":-19.951513,"median":-11.097535,"eighty":-6.330057,"marketCap":3046810149},{"date":"2023-07-28","current":-4.134728,"twenty":-19.945557,"median":-11.07773,"eighty":-6.267685,"marketCap":2973171233},{"date":"2023-08-04","current":-4.057384,"twenty":-19.897508,"median":-11.023587,"eighty":-6.244893,"marketCap":2924314645},{"date":"2023-08-11","current":-3.621915,"twenty":-19.755822,"median":-10.996766,"eighty":-6.219342,"marketCap":2610455224},{"date":"2023-08-18","current":-3.463233,"twenty":-19.719512,"median":-10.937719,"eighty":-6.110593,"marketCap":2496086977},{"date":"2023-08-25","current":-3.666544,"twenty":-19.634346,"median":-10.899761,"eighty":-5.986933,"marketCap":2642621293},{"date":"2023-09-01","current":-3.648692,"twenty":-19.538575,"median":-10.863505,"eighty":-5.82457,"marketCap":2629754865},{"date":"2023-09-08","current":-4.080109,"twenty":-19.362208,"median":-10.802755,"eighty":-5.750563,"marketCap":2940693535},{"date":"2023-09-15","current":-3.893658,"twenty":-19.077218,"median":-10.732491,"eighty":-5.672427,"marketCap":2806310846},{"date":"2023-09-22","current":-3.630841,"twenty":-18.981061,"median":-10.679378,"eighty":-5.619716,"marketCap":2616888437},{"date":"2023-09-29","current":-3.488027,"twenty":-18.845186,"median":-10.612101,"eighty":-5.581034,"marketCap":2513957016},{"date":"2023-10-06","current":-3.468192,"twenty":-18.69861,"median":-10.535971,"eighty":-5.490331,"marketCap":2499660985},{"date":"2023-10-13","current":-3.237111,"twenty":-18.632497,"median":-10.521807,"eighty":-5.460417,"marketCap":2333112226},{"date":"2023-10-20","current":-3.7042,"twenty":-18.632497,"median":-10.443907,"eighty":-5.405085,"marketCap":2669761173},{"date":"2023-10-27","current":-3.893405,"twenty":-18.654427,"median":-10.382839,"eighty":-5.365218,"marketCap":2806128470},{"date":"2023-11-03","current":-4.68465,"twenty":-18.654427,"median":-10.364295,"eighty":-5.28414,"marketCap":2976073660},{"date":"2023-11-10","current":-4.517051,"twenty":-18.654427,"median":-10.342873,"eighty":-5.170628,"marketCap":2869601414},{"date":"2023-11-17","current":-5.034024,"twenty":-18.654427,"median":-10.305516,"eighty":-5.093229,"marketCap":3198025038},{"date":"2023-11-24","current":-5.058581,"twenty":-18.654427,"median":-10.281065,"eighty":-5.066839,"marketCap":3213625160},{"date":"2023-12-01","current":-5.0211,"twenty":-18.654427,"median":-10.19999,"eighty":-5.05703,"marketCap":3189814448},{"date":"2023-12-08","current":-5.353255,"twenty":-18.644324,"median":-10.171258,"eighty":-5.057805,"marketCap":3400826626},{"date":"2023-12-15","current":-5.933557,"twenty":-18.644324,"median":-10.119914,"eighty":-5.057805,"marketCap":3769482144},{"date":"2023-12-22","current":-5.885737,"twenty":-18.644324,"median":-10.02608,"eighty":-5.057805,"marketCap":3739102959},{"date":"2023-12-29","current":-6.238571,"twenty":-18.654427,"median":-9.99662,"eighty":-5.05703,"marketCap":3963252082},{"date":"2024-01-05","current":-6.086064,"twenty":-18.664531,"median":-9.939328,"eighty":-5.056254,"marketCap":3866367113},{"date":"2024-01-12","current":-5.964576,"twenty":-18.664531,"median":-9.900378,"eighty":-5.056254,"marketCap":3789187561},{"date":"2024-01-19","current":-5.578138,"twenty":-18.674634,"median":-9.811733,"eighty":-5.055479,"marketCap":3543690902},{"date":"2024-01-26","current":-5.848257,"twenty":-18.664531,"median":-9.7849,"eighty":-5.056254,"marketCap":3715292246},{"date":"2024-02-02","current":-5.699627,"twenty":-18.664531,"median":-9.642907,"eighty":-5.056254,"marketCap":3620870454},{"date":"2024-02-09","current":-5.874105,"twenty":-18.664531,"median":-9.594133,"eighty":-5.056254,"marketCap":3731713427},{"date":"2024-02-16","current":-6.261086,"twenty":-18.664531,"median":-9.561842,"eighty":-5.056254,"marketCap":3798219211},{"date":"2024-02-23","current":-6.634206,"twenty":-18.664531,"median":-9.488533,"eighty":-5.056254,"marketCap":4024568380},{"date":"2024-03-01","current":-7.019664,"twenty":-18.654427,"median":-9.448218,"eighty":-5.05703,"marketCap":4258401731},{"date":"2024-03-08","current":-6.901583,"twenty":-18.618504,"median":-9.331505,"eighty":-5.05703,"marketCap":4186769683},{"date":"2024-03-15","current":-6.331541,"twenty":-18.555722,"median":-9.248631,"eighty":-5.05703,"marketCap":3840959798},{"date":"2024-03-22","current":-6.331541,"twenty":-18.362305,"median":-9.119934,"eighty":-5.05703,"marketCap":3840959798},{"date":"2024-03-28","current":-6.354614,"twenty":-18.110177,"median":-9.054151,"eighty":-5.05703,"marketCap":3854956865},{"date":"2024-04-05","current":-6.389903,"twenty":-17.885675,"median":-8.975116,"eighty":-5.056254,"marketCap":3876364143},{"date":"2024-04-12","current":-6.881225,"twenty":-17.643907,"median":-8.928874,"eighty":-5.056254,"marketCap":4174419330},{"date":"2024-04-19","current":-5.887723,"twenty":-17.405641,"median":-8.865305,"eighty":-5.056254,"marketCap":3571722102},{"date":"2024-04-26","current":-5.951513,"twenty":-17.24545,"median":-8.784804,"eighty":-5.05703,"marketCap":3610419874},{"date":"2024-05-03","current":-5.85531,"twenty":-17.111877,"median":-8.730843,"eighty":-5.05703,"marketCap":3591360331},{"date":"2024-05-10","current":-5.582669,"twenty":-17.109146,"median":-8.602772,"eighty":-5.05703,"marketCap":3424135754},{"date":"2024-05-17","current":-5.770925,"twenty":-17.109146,"median":-8.502293,"eighty":-5.05703,"marketCap":3539602729},{"date":"2024-05-24","current":-5.403894,"twenty":-17.109146,"median":-8.437742,"eighty":-5.05703,"marketCap":3314483663},{"date":"2024-05-31","current":-5.234599,"twenty":-17.109146,"median":-8.326018,"eighty":-5.05703,"marketCap":3210646455},{"date":"2024-06-07","current":-5.657159,"twenty":-17.109146,"median":-8.22856,"eighty":-5.05703,"marketCap":3469824125},{"date":"2024-06-14","current":-6.362758,"twenty":-17.109548,"median":-8.139615,"eighty":-5.056254,"marketCap":3902604231},{"date":"2024-06-21","current":-5.610206,"twenty":-17.10995,"median":-8.062414,"eighty":-5.055479,"marketCap":3441025345},{"date":"2024-06-28","current":-6.111908,"twenty":-17.111877,"median":-7.980946,"eighty":-5.053152,"marketCap":3748744602},{"date":"2024-07-05","current":-5.933361,"twenty":-17.111877,"median":-7.91653,"eighty":-5.053152,"marketCap":3639232749},{"date":"2024-07-12","current":-6.476379,"twenty":-17.111877,"median":-7.842615,"eighty":-5.053152,"marketCap":3972293592},{"date":"2024-07-15","current":-6.660828,"twenty":-17.111877,"median":-7.815809,"eighty":-5.053152,"marketCap":4085425672},{"date":"2024-08-02","current":-6.829058,"twenty":-17.121885,"median":-7.700275,"eighty":-5.034024,"marketCap":3995825065},{"date":"2024-08-09","current":-7.915825,"twenty":-17.121885,"median":-7.700012,"eighty":-5.034024,"marketCap":4631715386},{"date":"2024-08-16","current":-8.142486,"twenty":-17.121885,"median":-7.700012,"eighty":-5.034024,"marketCap":4764339569},{"date":"2024-08-23","current":-8.871265,"twenty":-17.121885,"median":-7.700012,"eighty":-5.034024,"marketCap":5190763157},{"date":"2024-08-30","current":-8.965707,"twenty":-17.121885,"median":-7.700012,"eighty":-5.034024,"marketCap":5246023233},{"date":"2024-09-06","current":-8.885431,"twenty":-17.121885,"median":-7.70624,"eighty":-5.034024,"marketCap":5199052169},{"date":"2024-09-13","current":-9.102648,"twenty":-17.121885,"median":-7.774964,"eighty":-5.034024,"marketCap":5326150344},{"date":"2024-09-20","current":-9.252181,"twenty":-17.121885,"median":-7.849896,"eighty":-5.034024,"marketCap":5413645465},{"date":"2024-09-27","current":-8.691824,"twenty":-17.121885,"median":-7.916177,"eighty":-5.034024,"marketCap":5085769012},{"date":"2024-10-04","current":-8.446275,"twenty":-17.121885,"median":-7.994412,"eighty":-5.034024,"marketCap":4942092814},{"date":"2024-10-11","current":-8.47933,"twenty":-17.121885,"median":-8.063851,"eighty":-5.034024,"marketCap":4961433841},{"date":"2024-10-18","current":-8.9358,"twenty":-17.121885,"median":-8.144847,"eighty":-5.034024,"marketCap":5228524209},{"date":"2024-10-25","current":-8.628863,"twenty":-17.121885,"median":-8.21254,"eighty":-5.034024,"marketCap":5048928962},{"date":"2024-10-31","current":-8.1598,"twenty":-17.121885,"median":-8.258605,"eighty":-5.034024,"marketCap":4774470583},{"date":"2024-11-08","current":-8.324768,"twenty":-17.142899,"median":-8.319439,"eighty":-5.03169,"marketCap":4653445648},{"date":"2024-11-15","current":-7.864207,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4395997435},{"date":"2024-11-22","current":-7.596785,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4246511376},{"date":"2024-11-29","current":-7.862556,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4395074682},{"date":"2024-12-06","current":-7.814684,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4368314832},{"date":"2024-12-13","current":-7.7404,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4326790927},{"date":"2024-12-20","current":-7.175841,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4011209247},{"date":"2024-12-27","current":-7.233618,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4043505617},{"date":"2025-01-03","current":-6.792866,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":3797130446},{"date":"2025-01-10","current":-7.205555,"twenty":-17.163913,"median":-8.328682,"eighty":-5.029355,"marketCap":4027818809},{"date":"2025-01-17","current":-6.743343,"twenty":-17.163913,"median":-8.303187,"eighty":-5.029355,"marketCap":3769447843},{"date":"2025-01-24","current":-7.403646,"twenty":-17.163913,"median":-8.22856,"eighty":-5.029355,"marketCap":4138549223},{"date":"2025-01-31","current":-7.164286,"twenty":-17.163913,"median":-8.210902,"eighty":-5.029355,"marketCap":4004749973},{"date":"2025-02-07","current":-7.557166,"twenty":-17.163913,"median":-8.156652,"eighty":-5.029355,"marketCap":4224365294},{"date":"2025-02-14","current":-7.055416,"twenty":-17.163913,"median":-8.140574,"eighty":-5.029355,"marketCap":4015823014},{"date":"2025-02-21","current":-7.228695,"twenty":-17.163913,"median":-8.07435,"eighty":-5.029355,"marketCap":4114450084},{"date":"2025-02-28","current":-6.82078,"twenty":-17.163913,"median":-8.063851,"eighty":-5.029355,"marketCap":3882272258},{"date":"2025-03-07","current":-6.503875,"twenty":-17.184926,"median":-8.040838,"eighty":-5.027021,"marketCap":3701895062},{"date":"2025-03-14","current":-6.378738,"twenty":-17.184926,"median":-8.040838,"eighty":-5.027021,"marketCap":3630669195},{"date":"2025-03-21","current":-6.320232,"twenty":-17.184926,"median":-8.040838,"eighty":-5.048263,"marketCap":3597368790},{"date":"2025-03-28","current":-6.320232,"twenty":-17.184926,"median":-8.040838,"eighty":-5.048263,"marketCap":3597368790},{"date":"2025-04-04","current":-5.709174,"twenty":-17.184926,"median":-8.040838,"eighty":-5.048263,"marketCap":3249564556},{"date":"2025-04-11","current":-5.389018,"twenty":-17.163913,"median":-8.038932,"eighty":-5.047263,"marketCap":3067337338},{"date":"2025-04-17","current":-5.770746,"twenty":-17.163913,"median":-7.988725,"eighty":-5.047263,"marketCap":3284610351},{"date":"2025-04-25","current":-6.209573,"twenty":-17.184926,"median":-7.897222,"eighty":-5.047026,"marketCap":3534383465},{"date":"2025-05-02","current":-6.428987,"twenty":-17.184926,"median":-7.862556,"eighty":-5.047026,"marketCap":3659270022},{"date":"2025-05-09","current":-6.178877,"twenty":-17.184926,"median":-7.798177,"eighty":-5.047026,"marketCap":3395781282},{"date":"2025-05-16","current":-5.983104,"twenty":-17.184926,"median":-7.720227,"eighty":-5.047026,"marketCap":3288188434},{"date":"2025-05-23","current":-6.098164,"twenty":-17.184926,"median":-7.659513,"eighty":-5.047026,"marketCap":3351422827},{"date":"2025-05-30","current":-6.015733,"twenty":-17.184926,"median":-7.598263,"eighty":-5.047026,"marketCap":3306120575},{"date":"2025-06-06","current":-6.338587,"twenty":-17.184926,"median":-7.557166,"eighty":-5.047026,"marketCap":3483554394},{"date":"2025-06-13","current":-6.747307,"twenty":-17.184926,"median":-7.489485,"eighty":-5.047026,"marketCap":3708178059},{"date":"2025-06-20","current":-6.414149,"twenty":-17.20594,"median":-7.434667,"eighty":-5.04679,"marketCap":3525081458},{"date":"2025-06-27","current":-6.374651,"twenty":-17.20594,"median":-7.397868,"eighty":-5.04679,"marketCap":3503374129},{"date":"2025-07-03","current":-6.85378,"twenty":-17.20594,"median":-7.331032,"eighty":-5.04679,"marketCap":3766693467},{"date":"2025-07-11","current":-5.329668,"twenty":-17.20594,"median":-7.284263,"eighty":-5.04679,"marketCap":2929073710},{"date":"2025-07-18","current":-4.707144,"twenty":-17.20594,"median":-7.231156,"eighty":-5.019717,"marketCap":2586947330},{"date":"2025-07-25","current":-4.688253,"twenty":-17.20594,"median":-7.2205,"eighty":-4.990742,"marketCap":2576565564},{"date":"2025-08-01","current":-4.691688,"twenty":-17.20594,"median":-7.178045,"eighty":-4.933118,"marketCap":2578453158},{"date":"2025-08-08","current":-5.023544,"twenty":-17.20594,"median":-7.165937,"eighty":-4.922401,"marketCap":2677207288},{"date":"2025-08-15","current":-5.236544,"twenty":-17.120341,"median":-7.127226,"eighty":-4.922401,"marketCap":2790721647},{"date":"2025-08-22","current":-5.328603,"twenty":-16.992353,"median":-7.100943,"eighty":-4.922401,"marketCap":2839782937},{"date":"2025-08-29","current":-5.469399,"twenty":-16.931942,"median":-7.088351,"eighty":-4.922401,"marketCap":2914817852},{"date":"2025-09-05","current":-5.646297,"twenty":-16.867084,"median":-7.050962,"eighty":-4.921583,"marketCap":3009092489},{"date":"2025-09-12","current":-5.637272,"twenty":-16.862117,"median":-7.009732,"eighty":-4.922401,"marketCap":3004282559},{"date":"2025-09-19","current":-5.254594,"twenty":-16.862117,"median":-6.97646,"eighty":-4.922401,"marketCap":2800341507},{"date":"2025-09-26","current":-5.021739,"twenty":-16.862117,"median":-6.933137,"eighty":-4.922401,"marketCap":2676245302},{"date":"2025-10-03","current":-5.577704,"twenty":-16.789633,"median":-6.862153,"eighty":-4.922401,"marketCap":2972537018},{"date":"2025-10-10","current":-5.71489,"twenty":-16.494533,"median":-6.851457,"eighty":-4.922401,"marketCap":3045647960},{"date":"2025-10-17","current":-6.131864,"twenty":-16.395701,"median":-6.820464,"eighty":-4.922401,"marketCap":3267866747},{"date":"2025-10-24","current":-6.070492,"twenty":-16.196687,"median":-6.815304,"eighty":-4.922401,"marketCap":3235159220},{"date":"2025-10-31","current":-6.348474,"twenty":-16.144099,"median":-6.798969,"eighty":-4.922401,"marketCap":3383305078},{"date":"2025-11-07","current":-5.140525,"twenty":-15.97004,"median":-6.764352,"eighty":-4.922401,"marketCap":2980625358},{"date":"2025-11-14","current":-5.464403,"twenty":-15.83132,"median":-6.73876,"eighty":-4.922401,"marketCap":3168419201},{"date":"2025-11-21","current":-5.178726,"twenty":-15.666995,"median":-6.672392,"eighty":-4.922401,"marketCap":3002775401},{"date":"2025-11-28","current":-5.771672,"twenty":-15.537051,"median":-6.632421,"eighty":-4.922401,"marketCap":3346582591},{"date":"2025-12-05","current":-6.068975,"twenty":-15.441819,"median":-6.604679,"eighty":-4.922401,"marketCap":3518967708},{"date":"2025-12-12","current":-6.012504,"twenty":-15.299877,"median":-6.546356,"eighty":-4.922401,"marketCap":3486224167},{"date":"2025-12-19","current":-5.454437,"twenty":-15.157139,"median":-6.505037,"eighty":-4.922401,"marketCap":3162640929},{"date":"2025-12-26","current":-5.743436,"twenty":-15.063399,"median":-6.472501,"eighty":-4.922401,"marketCap":3330210820},{"date":"2026-01-02","current":-3.820099,"twenty":-14.92224,"median":-6.441626,"eighty":-4.914015,"marketCap":2215004305},{"date":"2026-01-09","current":-3.854978,"twenty":-14.820259,"median":-6.429125,"eighty":-4.885543,"marketCap":2235228257},{"date":"2026-01-16","current":-3.903145,"twenty":-14.402748,"median":-6.402171,"eighty":-4.843904,"marketCap":2263156572},{"date":"2026-01-23","current":-3.886536,"twenty":-13.999808,"median":-6.386141,"eighty":-4.813839,"marketCap":2253526119},{"date":"2026-01-30","current":-4.031035,"twenty":-13.404405,"median":-6.378891,"eighty":-4.770249,"marketCap":2337311064},{"date":"2026-02-06","current":-3.951311,"twenty":-13.236481,"median":-6.373339,"eighty":-4.730852,"marketCap":2291084887},{"date":"2026-02-13","current":-3.935924,"twenty":-13.016417,"median":-6.357763,"eighty":-4.706612,"marketCap":2263156572},{"date":"2026-02-20","current":-3.660978,"twenty":-12.859995,"median":-6.338643,"eighty":-4.692375,"marketCap":2105062272},{"date":"2026-02-27","current":-3.8639,"twenty":-12.482459,"median":-6.324124,"eighty":-4.686998,"marketCap":2221742315},{"date":"2026-03-06","current":-3.598927,"twenty":-12.021549,"median":-6.305505,"eighty":-4.662679,"marketCap":2069383250},{"date":"2026-03-13","current":-3.640853,"twenty":-11.549025,"median":-6.278432,"eighty":-4.632225,"marketCap":2093490697},{"date":"2026-03-20","current":-3.424515,"twenty":-11.078073,"median":-6.266189,"eighty":-4.573889,"marketCap":1969096270},{"date":"2026-03-27","current":-3.35408,"twenty":-10.913611,"median":-6.247248,"eighty":-4.551596,"marketCap":1928595760}],"updateTime":1774774142617},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RARE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2623334248","title":"Is It Time To Reconsider Ultragenyx Pharmaceutical (RARE) After Its Prolonged Share Price Slump?","url":"https://stock-news.laohu8.com/highlight/detail?id=2623334248","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623334248?lang=en_us&edition=fundamental","pubTime":"2026-03-29 11:15","pubTimestamp":1774754110,"startTime":"0","endTime":"0","summary":"Wondering whether Ultragenyx Pharmaceutical at around US$19.38 is a bargain or a value trap? This breakdown will help you see what the current price is actually offering you.\nThe stock has had a tough run, with returns of a 2.5% decline over 7 days, 17.1% decline over 30 days, 17.9% decline year to date, 48.8% decline over 1 year, and 51.7% and 82.9% declines over 3 and 5 years, which naturally raises questions about how the market is now viewing its prospects and risk.\nRecent share price...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rare/ultragenyx-pharmaceutical/news/is-it-time-to-reconsider-ultragenyx-pharmaceutical-rare-afte-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rare/ultragenyx-pharmaceutical/news/is-it-time-to-reconsider-ultragenyx-pharmaceutical-rare-afte-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","BK4139","RARE"],"gpt_icon":0},{"id":"2622081918","title":"Ultragenyx announces annual stockholders meeting; FY2025 revenue grows 20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622081918","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622081918?lang=en_us&edition=fundamental","pubTime":"2026-03-28 04:32","pubTimestamp":1774643571,"startTime":"0","endTime":"0","summary":"Ultragenyx will hold its annual meeting on May 14, 2026 via a virtual webcast.Shareholders will vote on the election of three Class I director nominees: Emil D. Kakkis, Shehnaaz Suliman, and Daniel G. Welch.A proposal to approve the Third Amended and Restated 2023 Incentive Plan will be submitted, including an additional 3.0 million shares for issuance and extending the plan term through May 14, 2036.Shareholders will also vote on ratifying Ernst & Young as the independent registered public accounting firm for the year ending December 31, 2026, and on an advisory resolution on named executive officer compensation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ultragenyx Pharmaceutical Inc. published the original content used to genera","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL1ByjdR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2622828844","title":"BROAD ARROW PRESENTS RARE OPPORTUNITY TO ACQUIRE FERRARI MONZA SP2 AT CONCORSO D’ELEGANZA VILLA D’ESTE AUCTION","url":"https://stock-news.laohu8.com/highlight/detail?id=2622828844","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622828844?lang=en_us&edition=fundamental","pubTime":"2026-03-27 17:05","pubTimestamp":1774602300,"startTime":"0","endTime":"0","summary":"2020 FERRARI MONZA SP2 ONE OF ONLY 499 ICONA SERIES SP1 AND SP2 PRODUCED | STRIKING TAILOR MADE LIVERY IN TWO-TONE ROSSO CALIFORNIA WITH A GRIGIO COBURN NOSE SECTION AND ARGENTO NRBURGRING ACCENTS | EXTREMELY LOW MILEAGE EXAMPLE SHOWING ONLY 417 KILOMETRES | 6.5-LITRE NATURALLY ASPIRATED V12 PRODUCING 798 HP AND 719 NM OF TORQUE. 2020 Ferrari Monza SP2 set to be offered at Broad Arrow's Concorso d'Eleganza Villa d'Este Auction. Credit - Federico Vecchio/Courtesy of Broad Arrow Auctions","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/27/3263612/0/en/BROAD-ARROW-PRESENTS-RARE-OPPORTUNITY-TO-ACQUIRE-FERRARI-MONZA-SP2-AT-CONCORSO-D-ELEGANZA-VILLA-D-ESTE-AUCTION.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESTE","BK4585","BK4588","BK4139","BK4213","UK","BK4099","BK4528","HGTY","RACE","RARE","BK4205","BK4548","BK4173","BK4233","BK4555"],"gpt_icon":0},{"id":"2622020481","title":"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Alnylam Pharma (ALNY) and Ultragenyx Pharmaceutical (RARE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622020481","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622020481?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:10","pubTimestamp":1774437051,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Johnson & Johnson (JNJ), Alnylam Pharma (ALNY) and Ultragenyx Pha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-alnylam-pharma-alny-and-ultragenyx-pharmaceutical-rare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-alnylam-pharma-alny-and-ultragenyx-pharmaceutical-rare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJT1NW94.SGD","SG9999002232.USD","BK4588","IE00BKVL7J92.USD","IE00B42XCP33.USD","LU1430594728.SGD","LU1894683348.USD","XBI","SG9999001440.SGD","RARE","LU0128526141.USD","LU2471134523.USD","LU2129689514.USD","IE00B3T34201.USD","LU0203347892.USD","IE00B1BXHZ80.USD","HCSG","LU1983299246.USD","ALNY","JNJ","LU1935042991.SGD","BK4137","LU0345770993.USD","LU1074936037.SGD","LU2089984988.USD","BK4007","LU2505996681.GBP","LU0795875086.SGD","IE00BZ1G4Q59.USD","LABU","IE000M9KFDE8.USD","LU1221951129.SGD","BK4534","LU0234572021.USD","LU1674673428.USD","LU2430703251.USD","IE0002141913.USD","LU0345769128.USD","LU0466842654.USD","LU1261432733.SGD","BK4559","SG9999002224.SGD","XLV","IE00BN8TJ469.HKD","LU0683600562.USD","LU2505996509.AUD","LU1221951046.USD","LU0058720904.USD","LU1267930813.SGD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2622047429","title":"Why Ultragenyx (RARE) Is Down 14.4% After Positive Phase 3 DTX301 Gene Therapy Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2622047429","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622047429?lang=en_us&edition=fundamental","pubTime":"2026-03-25 14:04","pubTimestamp":1774418687,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical Inc. recently reported positive Phase 3 Enh3ance data for DTX301, its investigational AAV8 gene therapy for ornithine transcarbamylase (OTC) deficiency, showing a statistically significant 18% reduction in 24-hour plasma ammonia versus placebo and an overall acceptable safety profile.\nA particularly important finding was that treated patients generally maintained normal ammonia levels despite lowering ammonia scavenger use and increasing protein intake, hinting at...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rare/ultragenyx-pharmaceutical/news/why-ultragenyx-rare-is-down-144-after-positive-phase-3-dtx30","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rare/ultragenyx-pharmaceutical/news/why-ultragenyx-rare-is-down-144-after-positive-phase-3-dtx30","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AI","BK4528","BK4587","BK4585","BK4023","BK4139","BK4588","BK4543","RARE","AIYY","BK4551"],"gpt_icon":0},{"id":"2621069957","title":"Goldman Sachs Downgrades Ultragenyx Pharmaceutical to Neutral From Buy, Adjusts PT to $25 From $61","url":"https://stock-news.laohu8.com/highlight/detail?id=2621069957","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621069957?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:19","pubTimestamp":1774351183,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical (RARE) has an average rating of buy and mean price target of $52.45, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RARE"],"gpt_icon":0},{"id":"2621057512","title":"Ultragenyx downgraded to Neutral from Buy at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2621057512","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621057512?lang=en_us&edition=fundamental","pubTime":"2026-03-24 16:35","pubTimestamp":1774341319,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Salveen Richter downgraded Ultragenyx (RARE) to Neutral from Buy with a price target of $25, down from $61. The firm cites th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ultragenyx-downgraded-to-neutral-from-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ultragenyx-downgraded-to-neutral-from-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0251142724.SGD","IE0002270589.USD","BK4588","LU0345770993.USD","RARE","LU0251131958.USD","IE00BFXG1179.USD","LU1804176565.USD","LU1868836591.USD","IE0004086264.USD","GSX","LU2750360997.AUD","BK4552","IE00B19Z3B42.SGD","LU1894683264.USD","BK4516","LU1894683348.USD","LU2237443465.HKD","LU0061475181.USD","LU0096364046.USD","LU2471134879.HKD","BK4139","IE00BSNM7G36.USD","LU0742534661.SGD","LU0048573561.USD","LU1668664300.SGD","LU2750360641.GBP","LU1868837300.USD","LU2237443549.SGD","BK4585","LU2237443978.SGD","LU2471134952.CNY","IE0004091025.USD","BK4504","BK4127","LU0345770308.USD","LU1868836757.USD","LU1868836914.USD","LU2237443895.HKD","LU2265009873.SGD","LU2237438978.USD","LU1791807156.HKD","LU2237443622.USD","LU1868837136.USD","BK4533","LU2237443382.USD","BK4550","LU2471134796.USD","IE00B19Z3581.USD","LU0106831901.USD"],"gpt_icon":0},{"id":"2621286751","title":"Ultragenyx grants 10,839 restricted stock units under employment inducement plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2621286751","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621286751?lang=en_us&edition=fundamental","pubTime":"2026-03-21 04:30","pubTimestamp":1774038621,"startTime":"0","endTime":"0","summary":"Ultragenyx reported the grant of 10,839 restricted stock units to two newly hired non-executive officers under its Employment Inducement Plan.The awards have a grant date of March 16, 2026.The restricted stock units vest over four years, with 25% vesting on each anniversary of the grant date.Vesting is subject to the employee being continuously employed by the company on the applicable vesting dates.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nNDL655RDZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU2210150020.SGD","BK4588","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","SG9999014021.USD","SG9999014005.SGD","SG9999014039.USD","LU2210149790.SGD","NDAQ","IE00BGHQF748.EUR","RARE","LU0314104364.USD","BK4585","IE00BKPKM429.USD","IE00BN0W2W23.USD","SG9999014013.SGD","BK4139","LU2095319765.USD","IE00BN0W2T93.GBP","BK4112"],"gpt_icon":0},{"id":"2621754479","title":"Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2621754479","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621754479?lang=en_us&edition=fundamental","pubTime":"2026-03-21 04:30","pubTimestamp":1774038600,"startTime":"0","endTime":"0","summary":"NOVATO, Calif., March  20, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for r","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/20/3259953/20739/en/Ultragenyx-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RARE"],"gpt_icon":0},{"id":"2619227101","title":"Analysts Conflicted on These Healthcare Names: Immutep (IMMP) and Ultragenyx Pharmaceutical (RARE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2619227101","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619227101?lang=en_us&edition=fundamental","pubTime":"2026-03-15 00:20","pubTimestamp":1773505230,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Immutep (IMMP – Research Report) and Ultragenyx Pharmaceutical (R...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-immutep-immp-and-ultragenyx-pharmaceutical-rare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-immutep-immp-and-ultragenyx-pharmaceutical-rare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","BK4581","BK4139","LU0128526141.USD","BK4137","RARE","XBI","IMMP","XLV","LU0029874061.USD","LABU","HCSG"],"gpt_icon":0},{"id":"2619959155","title":"Ultragenyx's Gene Therapy Study Shows Ammonia Reduction In Rare Metabolic Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2619959155","media":"Benzinga_recent_news","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619959155?lang=en_us&edition=fundamental","pubTime":"2026-03-13 01:35","pubTimestamp":1773336900,"startTime":"0","endTime":"0","summary":"Ultragenyx Phase 3 gene therapy data shows reduced ammonia levels in rare disease patients, with further results expected in 2027.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/12/Gene-therapy.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/12/Gene-therapy.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/03/51221955/ultragenyxs-gene-therapy-study-shows-ammonia-reduction-in-rare-metabolic-disorder","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/03/51221955/ultragenyxs-gene-therapy-study-shows-ammonia-reduction-in-rare-metabolic-disorder","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["SMA","RARE","BK4139","BK4217"],"gpt_icon":0},{"id":"2618132864","title":"Ultragenyx's gene therapy helps control ammonia levels in late-stage study","url":"https://stock-news.laohu8.com/highlight/detail?id=2618132864","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618132864?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:36","pubTimestamp":1773319003,"startTime":"0","endTime":"0","summary":"Ultragenyx's gene therapy helps control ammonia levels in late-stage study March 12 (Reuters) - Ultragenyx Pharmaceutical RARE.O said on Thursday its experimental gene therapy helped patients in a lat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nL4N4001A0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RARE"],"gpt_icon":0},{"id":"2618132805","title":"Ultragenyx Phase 3 Enh3ance study showed statistically significant results","url":"https://stock-news.laohu8.com/highlight/detail?id=2618132805","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618132805?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:36","pubTimestamp":1773318978,"startTime":"0","endTime":"0","summary":"Ultragenyx (RARE) Pharmaceutical announced positive results from its Phase 3 Enh3ance study of DTX301, an investigational AAV8 gene therapy for the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ultragenyx-phase-3-enh3ance-study-showed-statistically-significant-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ultragenyx-phase-3-enh3ance-study-showed-statistically-significant-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2618134272","title":"Ultragenyx reports Phase 3 Enh3ance trial shows DTX301 cuts plasma ammonia AUC by 18% at Week 36","url":"https://stock-news.laohu8.com/highlight/detail?id=2618134272","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618134272?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:33","pubTimestamp":1773318800,"startTime":"0","endTime":"0","summary":"Ultragenyx reported positive 36-week results from the Phase 3 Enh3ance trial of DTX301, an investigational AAV8 gene therapy for ornithine transcarbamylase deficiency. In the randomized, double-blind, placebo-controlled period, DTX301  reduced 24-hour plasma ammonia AUC0-24 by 18% versus placebo  at Week 36 . The company also reported a mean 27% reduction in ammonia scavenger medications at Week 36 among treated patients. The study is continuing to a second primary endpoint evaluating treatment burden through 64 weeks of follow-up, with data expected in the first half of 2027.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nNDL3swplM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4585","LU2210149790.SGD","BK4112","LU2210150020.SGD","LU2095319765.USD","SG9999014005.SGD","LU0314104364.USD","BK4588","SG9999014013.SGD","IE00B3QW5Z07.USD","NDAQ","SG9999014021.USD","SG9999014039.USD","RARE","BK4139","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2618713448","title":"Ultragenyx Announces Positive 36-Week Data From Phase 3 Study of Dtx301 Aav8 Gene Therapy for the Treatment of Ornithine Transcarbamylase (Otc) Deficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2618713448","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618713448?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:30","pubTimestamp":1773318603,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nTUAGM4TB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RARE"],"gpt_icon":0},{"id":"2618424134","title":"Ultragenyx Pharmaceutical Inc - Dtx301 Shows 18% Reduction in 24-Hour Plasma Ammonia at Week 36 Versus Placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2618424134","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618424134?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:30","pubTimestamp":1773318603,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nTUAGM4TB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RARE"],"gpt_icon":0},{"id":"2618213443","title":"Ultragenyx Pharmaceutical Inc - Dtx301 Well Tolerated With Acceptable Safety Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2618213443","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618213443?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:30","pubTimestamp":1773318603,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nTUAGM4TB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2618134426","title":"Ultragenyx Pharmaceutical Inc - Fewer Hyperammonemic Crises and No Deaths in Dtx301 Group Compared to Placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2618134426","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618134426?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:30","pubTimestamp":1773318603,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nTUAGM4TB:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2618134425","title":"Ultragenyx Pharmaceutical Inc - Secondary Endpoint Data on Treatment Burden Reduction Expected First Half 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2618134425","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618134425?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:30","pubTimestamp":1773318603,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nTUAGM4TB:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RARE"],"gpt_icon":0},{"id":"2618460132","title":"Ultragenyx Announces Positive 36-Week Data from Phase 3 Study of DTX301 AAV8 Gene Therapy for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2618460132","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618460132?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:30","pubTimestamp":1773318600,"startTime":"0","endTime":"0","summary":"Statistically significant improvements in primary endpoint of ammonia control compared with placebo at 36 weeks Clinically important changes observed in patient global impression scale for overall OTC","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/12/3254660/20739/en/Ultragenyx-Announces-Positive-36-Week-Data-from-Phase-3-Study-of-DTX301-AAV8-Gene-Therapy-for-the-Treatment-of-Ornithine-Transcarbamylase-OTC-Deficiency.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RARE"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":196,"code":"91000000","status":"200"}]}}